Global Peripheral Chronic Total Occlusion Device Market Research Report 2024

Publication ID:

PB506242404

Publication Date:

June 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Peripheral Chronic Total Occlusion Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peripheral Chronic Total Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peripheral Chronic Total Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peripheral Chronic Total Occlusion Device include Medtronic Plc, Boston Scientific Corporation, Avinger, Inc., Cardinal Health, Koninklijke Philips N.V., Cook Medical Incorporated, C.R. Bard, Baylis Medical Company and BTG Vascular, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peripheral Chronic Total Occlusion Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Chronic Total Occlusion Device.
Report Scope
The Peripheral Chronic Total Occlusion Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Chronic Total Occlusion Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Chronic Total Occlusion Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic Plc
Boston Scientific Corporation
Avinger, Inc.
Cardinal Health
Koninklijke Philips N.V.
Cook Medical Incorporated
C.R. Bard
Baylis Medical Company
BTG Vascular
Soundbite Medical Solutions
Segment by Type
Micro Catheters
Guide Wires
Crossing Devices
Re-entry Devices
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peripheral Chronic Total Occlusion Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peripheral Chronic Total Occlusion Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Peripheral Chronic Total Occlusion Device Market Overview
1.1 Product Overview and Scope of Peripheral Chronic Total Occlusion Device
1.2 Peripheral Chronic Total Occlusion Device Segment by Type
1.2.1 Global Peripheral Chronic Total Occlusion Device Market Value Comparison by Type (2024-2030)
1.2.2 Micro Catheters
1.2.3 Guide Wires
1.2.4 Crossing Devices
1.2.5 Re-entry Devices
1.3 Peripheral Chronic Total Occlusion Device Segment by Application
1.3.1 Global Peripheral Chronic Total Occlusion Device Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Peripheral Chronic Total Occlusion Device Market Size Estimates and Forecasts
1.4.1 Global Peripheral Chronic Total Occlusion Device Revenue 2019-2030
1.4.2 Global Peripheral Chronic Total Occlusion Device Sales 2019-2030
1.4.3 Global Peripheral Chronic Total Occlusion Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peripheral Chronic Total Occlusion Device Market Competition by Manufacturers
2.1 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peripheral Chronic Total Occlusion Device Average Price by Manufacturers (2019-2024)
2.4 Global Peripheral Chronic Total Occlusion Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peripheral Chronic Total Occlusion Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peripheral Chronic Total Occlusion Device, Product Type & Application
2.7 Peripheral Chronic Total Occlusion Device Market Competitive Situation and Trends
2.7.1 Peripheral Chronic Total Occlusion Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peripheral Chronic Total Occlusion Device Players Market Share by Revenue
2.7.3 Global Peripheral Chronic Total Occlusion Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peripheral Chronic Total Occlusion Device Retrospective Market Scenario by Region
3.1 Global Peripheral Chronic Total Occlusion Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peripheral Chronic Total Occlusion Device Global Peripheral Chronic Total Occlusion Device Sales by Region: 2019-2030
3.2.1 Global Peripheral Chronic Total Occlusion Device Sales by Region: 2019-2024
3.2.2 Global Peripheral Chronic Total Occlusion Device Sales by Region: 2025-2030
3.3 Global Peripheral Chronic Total Occlusion Device Global Peripheral Chronic Total Occlusion Device Revenue by Region: 2019-2030
3.3.1 Global Peripheral Chronic Total Occlusion Device Revenue by Region: 2019-2024
3.3.2 Global Peripheral Chronic Total Occlusion Device Revenue by Region: 2025-2030
3.4 North America Peripheral Chronic Total Occlusion Device Market Facts & Figures by Country
3.4.1 North America Peripheral Chronic Total Occlusion Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peripheral Chronic Total Occlusion Device Sales by Country (2019-2030)
3.4.3 North America Peripheral Chronic Total Occlusion Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Peripheral Chronic Total Occlusion Device Market Facts & Figures by Country
3.5.1 Europe Peripheral Chronic Total Occlusion Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peripheral Chronic Total Occlusion Device Sales by Country (2019-2030)
3.5.3 Europe Peripheral Chronic Total Occlusion Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peripheral Chronic Total Occlusion Device Market Facts & Figures by Country
3.6.1 Asia Pacific Peripheral Chronic Total Occlusion Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peripheral Chronic Total Occlusion Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Peripheral Chronic Total Occlusion Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Peripheral Chronic Total Occlusion Device Market Facts & Figures by Country
3.7.1 Latin America Peripheral Chronic Total Occlusion Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peripheral Chronic Total Occlusion Device Sales by Country (2019-2030)
3.7.3 Latin America Peripheral Chronic Total Occlusion Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peripheral Chronic Total Occlusion Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Peripheral Chronic Total Occlusion Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peripheral Chronic Total Occlusion Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peripheral Chronic Total Occlusion Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Peripheral Chronic Total Occlusion Device Sales by Type (2019-2030)
4.1.1 Global Peripheral Chronic Total Occlusion Device Sales by Type (2019-2024)
4.1.2 Global Peripheral Chronic Total Occlusion Device Sales by Type (2025-2030)
4.1.3 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Type (2019-2030)
4.2 Global Peripheral Chronic Total Occlusion Device Revenue by Type (2019-2030)
4.2.1 Global Peripheral Chronic Total Occlusion Device Revenue by Type (2019-2024)
4.2.2 Global Peripheral Chronic Total Occlusion Device Revenue by Type (2025-2030)
4.2.3 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Type (2019-2030)
4.3 Global Peripheral Chronic Total Occlusion Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peripheral Chronic Total Occlusion Device Sales by Application (2019-2030)
5.1.1 Global Peripheral Chronic Total Occlusion Device Sales by Application (2019-2024)
5.1.2 Global Peripheral Chronic Total Occlusion Device Sales by Application (2025-2030)
5.1.3 Global Peripheral Chronic Total Occlusion Device Sales Market Share by Application (2019-2030)
5.2 Global Peripheral Chronic Total Occlusion Device Revenue by Application (2019-2030)
5.2.1 Global Peripheral Chronic Total Occlusion Device Revenue by Application (2019-2024)
5.2.2 Global Peripheral Chronic Total Occlusion Device Revenue by Application (2025-2030)
5.2.3 Global Peripheral Chronic Total Occlusion Device Revenue Market Share by Application (2019-2030)
5.3 Global Peripheral Chronic Total Occlusion Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic Plc
6.1.1 Medtronic Plc Corporation Information
6.1.2 Medtronic Plc Description and Business Overview
6.1.3 Medtronic Plc Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Plc Peripheral Chronic Total Occlusion Device Product Portfolio
6.1.5 Medtronic Plc Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Peripheral Chronic Total Occlusion Device Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Avinger, Inc.
6.3.1 Avinger, Inc. Corporation Information
6.3.2 Avinger, Inc. Description and Business Overview
6.3.3 Avinger, Inc. Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Avinger, Inc. Peripheral Chronic Total Occlusion Device Product Portfolio
6.3.5 Avinger, Inc. Recent Developments/Updates
6.4 Cardinal Health
6.4.1 Cardinal Health Corporation Information
6.4.2 Cardinal Health Description and Business Overview
6.4.3 Cardinal Health Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cardinal Health Peripheral Chronic Total Occlusion Device Product Portfolio
6.4.5 Cardinal Health Recent Developments/Updates
6.5 Koninklijke Philips N.V.
6.5.1 Koninklijke Philips N.V. Corporation Information
6.5.2 Koninklijke Philips N.V. Description and Business Overview
6.5.3 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Koninklijke Philips N.V. Peripheral Chronic Total Occlusion Device Product Portfolio
6.5.5 Koninklijke Philips N.V. Recent Developments/Updates
6.6 Cook Medical Incorporated
6.6.1 Cook Medical Incorporated Corporation Information
6.6.2 Cook Medical Incorporated Description and Business Overview
6.6.3 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cook Medical Incorporated Peripheral Chronic Total Occlusion Device Product Portfolio
6.6.5 Cook Medical Incorporated Recent Developments/Updates
6.7 C.R. Bard
6.6.1 C.R. Bard Corporation Information
6.6.2 C.R. Bard Description and Business Overview
6.6.3 C.R. Bard Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C.R. Bard Peripheral Chronic Total Occlusion Device Product Portfolio
6.7.5 C.R. Bard Recent Developments/Updates
6.8 Baylis Medical Company
6.8.1 Baylis Medical Company Corporation Information
6.8.2 Baylis Medical Company Description and Business Overview
6.8.3 Baylis Medical Company Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Baylis Medical Company Peripheral Chronic Total Occlusion Device Product Portfolio
6.8.5 Baylis Medical Company Recent Developments/Updates
6.9 BTG Vascular
6.9.1 BTG Vascular Corporation Information
6.9.2 BTG Vascular Description and Business Overview
6.9.3 BTG Vascular Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BTG Vascular Peripheral Chronic Total Occlusion Device Product Portfolio
6.9.5 BTG Vascular Recent Developments/Updates
6.10 Soundbite Medical Solutions
6.10.1 Soundbite Medical Solutions Corporation Information
6.10.2 Soundbite Medical Solutions Description and Business Overview
6.10.3 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Soundbite Medical Solutions Peripheral Chronic Total Occlusion Device Product Portfolio
6.10.5 Soundbite Medical Solutions Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peripheral Chronic Total Occlusion Device Industry Chain Analysis
7.2 Peripheral Chronic Total Occlusion Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peripheral Chronic Total Occlusion Device Production Mode & Process
7.4 Peripheral Chronic Total Occlusion Device Sales and Marketing
7.4.1 Peripheral Chronic Total Occlusion Device Sales Channels
7.4.2 Peripheral Chronic Total Occlusion Device Distributors
7.5 Peripheral Chronic Total Occlusion Device Customers
8 Peripheral Chronic Total Occlusion Device Market Dynamics
8.1 Peripheral Chronic Total Occlusion Device Industry Trends
8.2 Peripheral Chronic Total Occlusion Device Market Drivers
8.3 Peripheral Chronic Total Occlusion Device Market Challenges
8.4 Peripheral Chronic Total Occlusion Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic Plc
Boston Scientific Corporation
Avinger, Inc.
Cardinal Health
Koninklijke Philips N.V.
Cook Medical Incorporated
C.R. Bard
Baylis Medical Company
BTG Vascular
Soundbite Medical Solutions

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂